share_log

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $9

HC Wainwright & Co. Maintains Buy on Eton Pharmaceuticals, Lowers Price Target to $9

HC Wainwright & Co.維持對伊頓醫藥的買入,將目標股價下調至9美元
Benzinga Real-time News ·  2022/07/25 06:26

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and lowers the price target from $11 to $9.

HC Wainwright & Co. 分析師拉古拉姆·塞爾瓦拉朱維持伊頓製藥(納斯達克股票代碼:ETON)的買入並將目標股價從11美元下調至9美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論